'VunoMed DeepCAS Predicts Cardiac Arrest with AI, Accelerates Market Expansion'

Medical AI company VUNO announced on the 30th that its AI-based cardiac arrest prediction medical device, 'VUNO Med-DeepCARS,' has recorded the highest number of new hospital contracts and secured the largest number of beds on a monthly basis since its launch.

Operating screen of Vuno's AI-based cardiac arrest prediction medical device 'VunoMed DeepCARS'
[Photo by Vuno]

VUNO Med-DeepCARS is an AI medical device that analyzes vital sign data such as respiration, blood pressure, pulse, and body temperature of general ward inpatients to predict cardiac arrest within 24 hours. It has been designated as an advanced entry medical technology by the National Evidence-based Healthcare Collaborating Agency (NECA) and has entered the non-reimbursed market. It is used in a way that charges costs per bed on a daily basis proportional to actual usage.

VUNO explained that during this month alone, it completed product contracts for VUNO Med-DeepCARS with more than 10 medical institutions, including two tertiary general hospitals, and newly secured over 3,500 billable beds. The total number of billable beds has exceeded 28,000, and contracted hospitals amount to about 70 institutions, including 13 tertiary general hospitals. Additionally, demo and purchase procedures are underway at more than 40 other hospitals.

The company expects that as sales of VUNO Med-DeepCARS continue to rise, the possibility of reaching the break-even point is also increasing. They believe that the 'contribution margin,' which refers to the profit after deducting variable costs directly used to generate sales, is increasing. As the contribution margin rises, fixed costs can be covered, so the break-even point is expected to be reached sooner.

Im Seok-hoon, Head of Business at VUNO, said, "VUNO Med-DeepCARS had a good start this year by signing new contracts with more than 10 hospitals in just one month and securing many medical institutions that will convert to billing." He added, "This product acts as VUNO’s cash cow by generating cumulative sales in the form of Software as a Service (SaaS)."

This content was produced with the assistance of AI translation services.